On August 16, 2023, ImpediMed Limited announced that Michael Seiden MD, non-executive director of the Company supports the existing board of the Company. Additionally, Michael Seiden MD urged the shareholders to vote against the shareholder proposals for the removal of Donald Williams, Amit Patel, David Anderson and Daniel Sharp and the appointment of McGregor Grant, Christine Emmanuel-Donnelly, Andrew Grant and Janelle Delaney as the director of the Company